Novita Pharmaceuticals' Unattributed Round

Novita Pharmaceuticals raised a round of funding on January 05, 2011.

Novita Pharmaceuticals is developing new drug molecules to prevent cancer metastasis by targeting a new gene target, fascin.…

Articles about Novita Pharmaceuticals' Unattributed Round: